Scoop: Led by former Trump official, Altesa BioSciences raises $35M for antivirals, recruits Moncef Slaoui to board
Altesa BioSciences has raised a $35 million Series A from undisclosed investors, according to an SEC filing from July. The company develops antiviral drugs for chronic obstructive pulmonary disease from viruses that cause the common cold.
The College Park, GA-based startup is led by Brett Giroir, the former assistant secretary for health in the Department of Health and Human Services during the Trump administration, acting FDA commissioner and admiral.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.